73/100B904.38
USD
1.56
(0.17%)
Pre Open·910.20USD+5.82(+0.64%)
Last updated: · Delayed 15 min
Fair value814.64Plus+11%346Price 904.381,431
Q4 FY2026 · Earnings report
EPS estimate 25.39Revenue estimate 5.85B
Q4 FY2026 · Earnings report
EPS estimate 25.39Revenue estimate 5.85B
Regeneron Pharmaceuticals current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Regeneron Pharmaceuticals's current ratio is 3.35: current assets of 20.80B USD against current liabilities of 6.20B USD due within a year.
- Today
- 3.35
- Average, 5 years
- 4.72
- Low, 5 years
- 3.34
- High, 5 years
- 5.69
Current ratio = current assets ÷ current liabilities = 20.80B ÷ 6.20B = 3.35
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 3.35 | 20.80B | 6.20B | |
| FY2025 | 31 Dec 2025 | 4.13 | 18.02B | 4.37B |
| FY2024 | 31 Dec 2024 | 4.73 | 18.66B | 3.94B |
| FY2023 | 31 Dec 2023 | 5.69 | 19.48B | 3.42B |
| FY2022 | 31 Dec 2022 | 5.06 | 15.88B | 3.14B |
| FY2021 | 31 Dec 2021 | 3.56 | 14.01B | 3.93B |
| FY2020 | 31 Dec 2020 | 3.63 | 9.78B | 2.70B |
| FY2019 | 31 Dec 2019 | 3.67 | 7.69B | 2.10B |
| FY2018 | 31 Dec 2018 | 5.52 | 7.96B | 1.44B |
| FY2017 | 31 Dec 2017 | 4.93 | 5.60B | 1.14B |
| FY2016 | 31 Dec 2016 | 3.15 | 3.91B | 1.24B |
| FY2015 | 31 Dec 2015 | 4.17 | 3.38B | 811.16M |
| FY2014 | 31 Dec 2014 | 3.83 | 2.51B | 654.66M |
| FY2013 | 31 Dec 2013 | 7.54 | 2.25B | 298.84M |
| FY2012 | 31 Dec 2012 | 9.91 | 1.62B | 163.55M |
| FY2011 | 31 Dec 2011 | 6.16 | 913.59M | 148.27M |
| FY2010 | 31 Dec 2010 | 6.60 | 720.05M | 109.06M |
| FY2009 | 31 Dec 2009 | 4.55 | 425.51M | 93.58M |
| FY2008 | 31 Dec 2008 | 6.23 | 521.44M | 83.67M |
| FY2007 | 31 Dec 2007 | 2.81 | 797.83M | 283.66M |
| FY2006 | 31 Dec 2006 | 10.44 | 469.98M | 45.01M |
| FY2005 | 31 Dec 2005 | 8.46 | 341.39M | 40.36M |
| FY2004 | 31 Dec 2004 | 10.08 | 343.96M | 34.14M |
| FY2003 | 31 Dec 2003 | 4.39 | 320.21M | 72.92M |
| FY2002 | 31 Dec 2002 | 6.90 | 276.95M | 40.12M |
| FY2001 | 31 Dec 2001 | 17.90 | 394.19M | 22.02M |
| FY2000 | 31 Dec 2000 | 9.73 | 134.14M | 13.79M |
| FY1999 | 31 Dec 1999 | 5.49 | 73.00M | 13.30M |
| FY1998 | 31 Dec 1998 | 9.88 | 92.90M | 9.40M |
| FY1997 | 31 Dec 1997 | 9.31 | 99.60M | 10.70M |
| FY1996 | 31 Dec 1996 | 7.08 | 85.00M | 12.00M |
| FY1995 | 31 Dec 1995 | 3.81 | 49.20M | 12.90M |
| FY1994 | 31 Dec 1994 | 2.91 | 52.00M | 17.90M |
| FY1993 | 31 Dec 1993 | 7.01 | 91.80M | 13.10M |
| FY1992 | 31 Dec 1992 | 18.41 | 84.70M | 4.60M |
| FY1991 | 31 Dec 1991 | 32.30 | 106.60M | 3.30M |
| FY1990 | 31 Dec 1990 | 12.44 | 22.40M | 1.80M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 3.35 | 20.80B | 6.20B |
| Q2 FY2026 | 30 Jun 2026 | 3.34 | 18.45B | 5.53B |
| Q1 FY2026 | 31 Mar 2026 | 3.57 | 18.21B | 5.11B |
| Q4 FY2025 | 31 Dec 2025 | 4.13 | 18.02B | 4.37B |
| Q3 FY2025 | 30 Sept 2025 | 4.06 | 17.98B | 4.43B |
| Q2 FY2025 | 30 Jun 2025 | 4.60 | 16.86B | 3.67B |
| Q1 FY2025 | 31 Mar 2025 | 4.93 | 17.57B | 3.57B |
| Q4 FY2024 | 31 Dec 2024 | 4.73 | 18.66B | 3.94B |
| Q3 FY2024 | 30 Sept 2024 | 5.28 | 19.33B | 3.66B |
| Q2 FY2024 | 30 Jun 2024 | 5.44 | 19.08B | 3.51B |
| Q1 FY2024 | 31 Mar 2024 | 5.27 | 18.87B | 3.58B |
| Q4 FY2023 | 31 Dec 2023 | 5.69 | 19.48B | 3.42B |
| Q3 FY2023 | 30 Sept 2023 | 5.18 | 18.63B | 3.60B |
| Q2 FY2023 | 30 Jun 2023 | 5.45 | 16.92B | 3.10B |
| Q1 FY2023 | 31 Mar 2023 | 5.45 | 16.91B | 3.10B |
| Q4 FY2022 | 31 Dec 2022 | 5.06 | 15.88B | 3.14B |
| Q3 FY2022 | 30 Sept 2022 | 5.36 | 15.43B | 2.88B |
| Q2 FY2022 | 30 Jun 2022 | 5.12 | 15.53B | 3.03B |
| Q1 FY2022 | 31 Mar 2022 | 4.76 | 14.31B | 3.01B |
| Q4 FY2021 | 31 Dec 2021 | 3.56 | 14.01B | 3.93B |
| Q3 FY2021 | 30 Sept 2021 | 3.71 | 13.78B | 3.71B |
| Q2 FY2021 | 30 Jun 2021 | 3.57 | 13.34B | 3.73B |
| Q1 FY2021 | 31 Mar 2021 | 3.12 | 10.06B | 3.22B |
| Q4 FY2020 | 31 Dec 2020 | 3.63 | 9.78B | 2.70B |
| Q3 FY2020 | 30 Sept 2020 | 3.89 | 9.10B | 2.34B |
| Q2 FY2020 | 30 Jun 2020 | 2.12 | 7.86B | 3.70B |
| Q1 FY2020 | 31 Mar 2020 | 4.21 | 8.64B | 2.06B |
| Q4 FY2019 | 31 Dec 2019 | 3.67 | 7.69B | 2.10B |
| Q3 FY2019 | 30 Sept 2019 | 4.03 | 7.11B | 1.77B |
| Q2 FY2019 | 30 Jun 2019 | 3.88 | 6.65B | 1.71B |
| Q1 FY2019 | 31 Mar 2019 | 4.58 | 6.93B | 1.51B |
| Q4 FY2018 | 31 Dec 2018 | 5.52 | 7.96B | 1.44B |
| Q3 FY2018 | 30 Sept 2018 | 4.04 | 5.72B | 1.42B |
| Q2 FY2018 | 30 Jun 2018 | 5.03 | 6.70B | 1.33B |
| Q1 FY2018 | 31 Mar 2018 | 3.59 | 4.54B | 1.27B |
| Q4 FY2017 | 31 Dec 2017 | 4.93 | 5.60B | 1.14B |
| Q3 FY2017 | 30 Sept 2017 | 3.63 | 4.14B | 1.14B |
| Q2 FY2017 | 30 Jun 2017 | 3.75 | 3.86B | 1.03B |
| Q1 FY2017 | 31 Mar 2017 | 2.80 | 3.67B | 1.31B |
| Q4 FY2016 | 31 Dec 2016 | 3.15 | 3.91B | 1.24B |
| Q3 FY2016 | 30 Sept 2016 | 3.64 | 3.50B | 961.19M |
| Q2 FY2016 | 30 Jun 2016 | 3.37 | 3.21B | 951.56M |
| Q1 FY2016 | 31 Mar 2016 | 3.41 | 3.13B | 919.72M |
| Q4 FY2015 | 31 Dec 2015 | 4.17 | 3.38B | 811.16M |
| Q3 FY2015 | 30 Sept 2015 | 3.64 | 2.68B | 734.99M |
| Q2 FY2015 | 30 Jun 2015 | 3.80 | 2.28B | 601.54M |
| Q1 FY2015 | 31 Mar 2015 | 4.31 | 2.31B | 536.13M |
| Q4 FY2014 | 31 Dec 2014 | 3.83 | 2.51B | 654.66M |
| Q3 FY2014 | 30 Sept 2014 | 5.36 | 2.20B | 410.20M |
| Q2 FY2014 | 30 Jun 2014 | 5.46 | 1.92B | 351.58M |
| Q1 FY2014 | 31 Mar 2014 | 6.13 | 1.87B | 305.07M |
| Q4 FY2013 | 31 Dec 2013 | 7.54 | 2.25B | 298.84M |
| Q3 FY2013 | 30 Sept 2013 | 6.08 | 1.63B | 268.73M |
| Q2 FY2013 | 30 Jun 2013 | 7.66 | 1.56B | 203.80M |
| Q1 FY2013 | 31 Mar 2013 | 6.63 | 1.31B | 197.24M |
| Q4 FY2012 | 31 Dec 2012 | 9.91 | 1.62B | 163.55M |
| Q3 FY2012 | 30 Sept 2012 | 5.31 | 948.60M | 178.57M |
| Q2 FY2012 | 30 Jun 2012 | 4.20 | 769.19M | 183.22M |
| Q1 FY2012 | 31 Mar 2012 | 4.35 | 696.92M | 160.39M |
| Q4 FY2011 | 31 Dec 2011 | 4.40 | 652.88M | 148.27M |
| Q3 FY2011 | 30 Sept 2011 | 2.55 | 339.87M | 133.24M |
| Q2 FY2011 | 30 Jun 2011 | 3.04 | 413.27M | 135.87M |
| Q1 FY2011 | 31 Mar 2011 | 6.20 | 695.74M | 112.25M |
| Q4 FY2010 | 31 Dec 2010 | 6.60 | 720.05M | 109.06M |
| Q3 FY2010 | 30 Sept 2010 | 4.30 | 575.72M | 133.83M |
| Q2 FY2010 | 30 Jun 2010 | 3.49 | 417.75M | 119.57M |
| Q1 FY2010 | 31 Mar 2010 | 3.80 | 395.44M | 104.09M |
| Q4 FY2009 | 31 Dec 2009 | 4.55 | 425.51M | 93.58M |
| Q3 FY2009 | 30 Sept 2009 | 4.04 | 461.59M | 114.17M |
| Q2 FY2009 | 30 Jun 2009 | 4.37 | 526.41M | 120.42M |
| Q1 FY2009 | 31 Mar 2009 | 4.69 | 483.79M | 103.11M |
| Q4 FY2008 | 31 Dec 2008 | 6.23 | 521.44M | 83.67M |
| Q3 FY2008 | 30 Sept 2008 | 3.29 | 715.54M | 217.77M |
| Q2 FY2008 | 30 Jun 2008 | 3.32 | 742.39M | 223.92M |
| Q1 FY2008 | 31 Mar 2008 | 2.75 | 787.51M | 285.95M |
| Q4 FY2007 | 31 Dec 2007 | 2.81 | 797.83M | 283.66M |
| Q3 FY2007 | 30 Sept 2007 | 4.36 | 422.02M | 96.69M |
| Q2 FY2007 | 30 Jun 2007 | 4.74 | 496.98M | 104.83M |
| Q1 FY2007 | 31 Mar 2007 | 5.85 | 489.16M | 83.60M |
| Q4 FY2006 | 31 Dec 2006 | 10.44 | 469.98M | 45.01M |
| Q3 FY2006 | 30 Sept 2006 | 8.37 | 273.75M | 32.70M |
| Q2 FY2006 | 30 Jun 2006 | 9.24 | 291.06M | 31.51M |
| Q1 FY2006 | 31 Mar 2006 | 9.49 | 319.65M | 33.67M |
| Q4 FY2005 | 31 Dec 2005 | 8.46 | 341.39M | 40.36M |
| Q3 FY2005 | 30 Sept 2005 | 9.69 | 324.96M | 33.52M |
| Q2 FY2005 | 30 Jun 2005 | 12.00 | 359.31M | 29.95M |
| Q1 FY2005 | 31 Mar 2005 | 12.36 | 369.85M | 29.93M |
| Q4 FY2004 | 31 Dec 2004 | 10.08 | 343.96M | 34.14M |
| Q3 FY2004 | 30 Sept 2004 | 8.67 | 311.24M | 35.90M |
| Q2 FY2004 | 30 Jun 2004 | 10.26 | 383.33M | 37.37M |
| Q1 FY2004 | 31 Mar 2004 | 10.80 | 392.28M | 36.34M |
| Q4 FY2003 | 31 Dec 2003 | 4.39 | 320.21M | 72.92M |
| Q3 FY2003 | 30 Sept 2003 | 7.39 | 404.38M | 54.74M |
| Q2 FY2003 | 30 Jun 2003 | 6.02 | 295.15M | 49.06M |
| Q1 FY2003 | 31 Mar 2003 | 5.55 | 329.74M | 59.37M |
| Q4 FY2002 | 31 Dec 2002 | 6.90 | 276.95M | 40.12M |
| Q3 FY2002 | 30 Sept 2002 | 9.61 | 313.82M | 32.65M |
| Q2 FY2002 | 30 Jun 2002 | 14.42 | 309.71M | 21.48M |
| Q1 FY2002 | 31 Mar 2002 | 14.69 | 337.12M | 22.94M |
| Q4 FY2001 | 31 Dec 2001 | 17.90 | 394.19M | 22.02M |
| Q3 FY2001 | 30 Sept 2001 | 17.53 | 252.73M | 14.42M |
| Q2 FY2001 | 30 Jun 2001 | 19.56 | 252.78M | 12.93M |
| Q1 FY2001 | 31 Mar 2001 | 20.69 | 286.64M | 13.86M |
| Q4 FY2000 | 31 Dec 2000 | 9.73 | 134.14M | 13.79M |
| Q3 FY2000 | 30 Sept 2000 | 10.75 | 137.00M | 12.74M |
| Q2 FY2000 | 30 Jun 2000 | 10.55 | 137.46M | 13.03M |
| Q1 FY2000 | 31 Mar 2000 | 5.90 | 73.48M | 12.45M |
| Q4 FY1999 | 31 Dec 1999 | 5.49 | 73.00M | 13.30M |
| Q3 FY1999 | 30 Sept 1999 | 8.34 | 74.20M | 8.90M |
| Q2 FY1999 | 30 Jun 1999 | 8.76 | 76.20M | 8.70M |
| Q1 FY1999 | 31 Mar 1999 | 7.70 | 76.20M | 9.90M |
| Q4 FY1998 | 31 Dec 1998 | 9.88 | 92.90M | 9.40M |
| Q3 FY1998 | 30 Sept 1998 | 9.29 | 89.20M | 9.60M |
| Q2 FY1998 | 30 Jun 1998 | 10.40 | 88.40M | 8.50M |
| Q1 FY1998 | 31 Mar 1998 | 12.12 | 90.90M | 7.50M |
| Q4 FY1997 | 31 Dec 1997 | 9.31 | 99.60M | 10.70M |
| Q3 FY1997 | 30 Sept 1997 | 13.09 | 102.10M | 7.80M |
| Q2 FY1997 | 30 Jun 1997 | 10.24 | 110.60M | 10.80M |
| Q1 FY1997 | 31 Mar 1997 | 7.41 | 71.90M | 9.70M |
| Q4 FY1996 | 31 Dec 1996 | 7.08 | 85.00M | 12.00M |
| Q3 FY1996 | 30 Sept 1996 | 8.25 | 73.40M | 8.90M |
| Q2 FY1996 | 30 Jun 1996 | 8.51 | 81.70M | 9.60M |
| Q1 FY1996 | 31 Mar 1996 | 3.67 | 38.50M | 10.50M |
| Q4 FY1995 | 31 Dec 1995 | 3.81 | 49.20M | 12.90M |
| Q3 FY1995 | 30 Sept 1995 | 2.17 | 30.60M | 14.10M |
| Q2 FY1995 | 30 Jun 1995 | 2.44 | 39.50M | 16.20M |
| Q1 FY1995 | 31 Mar 1995 | 2.77 | 37.90M | 13.70M |
| Q4 FY1994 | 31 Dec 1994 | 2.91 | 52.00M | 17.90M |
| Q3 FY1994 | 30 Sept 1994 | 2.85 | 47.00M | 16.50M |
| Q2 FY1994 | 30 Jun 1994 | 2.55 | 55.30M | 21.70M |
| Q1 FY1994 | 31 Mar 1994 | 4.05 | 44.60M | 11.00M |
| Q4 FY1993 | 31 Dec 1993 | 7.01 | 91.80M | 13.10M |
| Q3 FY1993 | 30 Sept 1993 | 11.66 | 109.60M | 9.40M |
| Q2 FY1993 | 30 Jun 1993 | 9.15 | 67.70M | 7.40M |
| Q1 FY1993 | 31 Mar 1993 | 12.39 | 76.80M | 6.20M |
| Q4 FY1992 | 31 Dec 1992 | 18.41 | 84.70M | 4.60M |
| Q3 FY1992 | 30 Sept 1992 | 17.34 | 91.90M | 5.30M |
| Q2 FY1992 | 30 Jun 1992 | 23.19 | 97.40M | 4.20M |
| Q1 FY1992 | 31 Mar 1992 | 25.60 | 102.40M | 4.00M |
| Q4 FY1991 | 31 Dec 1991 | 32.30 | 106.60M | 3.30M |
| Q3 FY1991 | 30 Sept 1991 | 52.19 | 109.60M | 2.10M |
| Q2 FY1991 | 30 Jun 1991 | 55.65 | 111.30M | 2.00M |
| Q1 FY1991 | 31 Mar 1991 | — | — | — |
| Q4 FY1990 | 31 Dec 1990 | 12.44 | 22.40M | 1.80M |
| Q3 FY1990 | 30 Sept 1990 | — | — | — |
| Q2 FY1990 | 30 Jun 1990 | — | — | — |
| Q1 FY1990 | 31 Mar 1990 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,All ratios
Common questions about Regeneron Pharmaceuticals's current ratio
Source: Financial Modeling Prep